CN Stock MarketDetailed Quotes

Hybio Pharmaceutical (300199)

Watchlist
  • 20.46
  • -0.52-2.48%
Noon Break May 8 11:30 CST
18.07BMarket Cap191.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hybio Pharmaceutical (300199) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Raw material medicine438.09M45.33%
Preparation430.19M44.52%
Other business38.63M4.00%
Customer peptide28.58M2.96%
Solid class27.35M2.83%
大消费品及其他3.52M0.36%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry966.35M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Overseas598.42M61.93%
Territory367.93M38.07%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 0.00%
Sample Name
Sample Code
 -0.53%
4
SINOPEC CORP
00386
-0.86%
5
PETROCHINA
00857
-1.67%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +63.02%
Sample Name
Sample Code
 +51.73%
Sample Name
Sample Code
 +46.31%
4
Loongson Technology Corporation
688047
+36.06%
5
Business-intelligence Of Oriental Nations Corporation
300166
+32.07%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -